Esperion Therapeutics ESPR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's operating lease ROU assets?
- Esperion Therapeutics (ESPR) reported operating lease ROU assets of $2.7M in Q1 2026.
- How has Esperion Therapeutics's operating lease ROU assets changed year-over-year?
- Esperion Therapeutics's operating lease ROU assets decreased by 45.6% year-over-year, from $4.97M to $2.7M.
- What is the long-term trend for Esperion Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Esperion Therapeutics's operating lease ROU assets has grown at a 3739.9% compound annual growth rate (CAGR), from $0.04 to $2.92M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.